Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Burga

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|November 12, 2016
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumorsElizabeth E Sweeney, Rachel A Burga, Chaoyang Li, et al.
Biomaterials|April 26, 2012
A functional agarose-hydroxyapatite scaffold for osteochondral interface regenerationNora T Khanarian, Nora M Haney, Rachel A Burga, et al.
Bioconjugate Chemistry|February 20, 2019
Designing Magnetically Responsive Biohybrids Composed of Cord Blood-Derived Natural Killer Cells and Iron Oxide NanoparticlesRachel A Burga, Daud H Khan, Nitin Agrawal, et al.
Nanomedicine (London, England)|July 9, 2016
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyRachel A Burga, Shabnum Patel, Catherine M Bollard, et al.
Advanced Nanobiomed Research|August 26, 2021
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma ModelAnshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, et al.
Cytotherapy|July 17, 2016
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cellsRachel A Burga, Tuongvan Nguyen, Jane Zulovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.
Journal of Leukocyte Biology|August 3, 2014
Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cellsMitchell Thorn, Gary R Point, Rachel A Burga, et al.
Cytotherapy|March 11, 2023
Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual MeetingMargaret Lamb, Elani Wiest, Anthony Filiano, et al.
Cytotherapy|March 25, 2025
Entering a new era of tumor-infiltrating lymphocyte cell therapy innovationRodabe N Amaria, Krishna V Komanduri, Adam J Schoenfeld, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|November 12, 2016
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumorsElizabeth E Sweeney, Rachel A Burga, Chaoyang Li, et al.
Biomaterials|April 26, 2012
A functional agarose-hydroxyapatite scaffold for osteochondral interface regenerationNora T Khanarian, Nora M Haney, Rachel A Burga, et al.
Bioconjugate Chemistry|February 20, 2019
Designing Magnetically Responsive Biohybrids Composed of Cord Blood-Derived Natural Killer Cells and Iron Oxide NanoparticlesRachel A Burga, Daud H Khan, Nitin Agrawal, et al.
Nanomedicine (London, England)|July 9, 2016
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyRachel A Burga, Shabnum Patel, Catherine M Bollard, et al.
Advanced Nanobiomed Research|August 26, 2021
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma ModelAnshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, et al.
Cytotherapy|July 17, 2016
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cellsRachel A Burga, Tuongvan Nguyen, Jane Zulovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.
Journal of Leukocyte Biology|August 3, 2014
Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cellsMitchell Thorn, Gary R Point, Rachel A Burga, et al.
Cytotherapy|March 11, 2023
Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual MeetingMargaret Lamb, Elani Wiest, Anthony Filiano, et al.
Cytotherapy|March 25, 2025
Entering a new era of tumor-infiltrating lymphocyte cell therapy innovationRodabe N Amaria, Krishna V Komanduri, Adam J Schoenfeld, et al.
Pageof 3